Patricia Haus

Title: Patricia Haus: Innovator in HDAC Inhibitors

Introduction

Patricia Haus is a prominent inventor based in Laudenbach, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of selective HDAC8 inhibitors. Her work focuses on small molecule compounds that have the potential to impact cancer treatment and therapeutic applications for eukaryotic parasites.

Latest Patents

Patricia Haus holds 1 patent for her invention titled "Selective HDAC8 inhibitors and their uses." This patent describes small molecule compounds based on benzopyrimido- or benzoimidazo-thiazin-imine, along with their synthesis intermediates. The invention emphasizes the use of these compounds as HDAC inhibitors, specifically targeting HDAC8, and outlines their potential applications in treating cancer and other diseases.

Career Highlights

Patricia is affiliated with Hochschule Darmstadt, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the field of HDAC inhibitors, contributing to advancements in cancer therapy and parasitic treatments.

Collaborations

Throughout her career, Patricia has collaborated with notable colleagues, including Franz-Josef Meyer-Almes and Christian Meyners. These partnerships have enhanced her research and broadened the impact of her inventions.

Conclusion

Patricia Haus exemplifies the spirit of innovation in the field of medicinal chemistry. Her contributions to the development of selective HDAC8 inhibitors highlight her commitment to advancing therapeutic options for cancer and other diseases.